111 related articles for article (PubMed ID: 28452475)
1. Hydrolysis in Acidic Environment and Degradation of Satraplatin: A Joint Experimental and Theoretical Investigation.
Ritacco I; Al Assy M; Abd El-Rahman MK; Fahmy SA; Russo N; Shoeib T; Sicilia E
Inorg Chem; 2017 May; 56(10):6013-6026. PubMed ID: 28452475
[TBL] [Abstract][Full Text] [Related]
2. Can Satraplatin be hydrated before the reduction process occurs? The DFT computational study.
Bradáč O; Zimmermann T; Burda JV
J Mol Model; 2013 Nov; 19(11):4669-80. PubMed ID: 22643969
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by Acetates.
Karmakar S; Poetsch I; Kowol CR; Heffeter P; Gibson D
Inorg Chem; 2019 Dec; 58(24):16676-16688. PubMed ID: 31790216
[TBL] [Abstract][Full Text] [Related]
4. Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione.
Kostrhunova H; Kasparkova J; Gibson D; Brabec V
Mol Pharm; 2010 Dec; 7(6):2093-102. PubMed ID: 20936822
[TBL] [Abstract][Full Text] [Related]
5. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
6. A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes.
Corinti D; Crestoni ME; Fornarini S; Dabbish E; Sicilia E; Gabano E; Perin E; Osella D
J Biol Inorg Chem; 2020 Jun; 25(4):655-670. PubMed ID: 32296997
[TBL] [Abstract][Full Text] [Related]
7. The gas-phase chemistry of cis-diammineplatinum(II) complexes: a joint experimental and theoretical study.
Springer A; Bürgel C; Böhrsch V; Mitrić R; Bonacić-Koutecký V; Linscheid MW
Chemphyschem; 2006 Aug; 7(8):1779-85. PubMed ID: 16847840
[TBL] [Abstract][Full Text] [Related]
8. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometric and Computational Investigation of the Protonated Carnosine-Carboplatin Complex Fragmentation.
Ritacco I; Sicilia E; Shoeib T; Korany M; Russo N
Inorg Chem; 2015 Aug; 54(16):7885-97. PubMed ID: 26238420
[TBL] [Abstract][Full Text] [Related]
10. Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.
Lucas MF; Pavelka M; Alberto ME; Russo N
J Phys Chem B; 2009 Jan; 113(3):831-8. PubMed ID: 19143575
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
Ritacco I; Mazzone G; Russo N; Sicilia E
Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
[TBL] [Abstract][Full Text] [Related]
12. Satraplatin: an orally available platinum analog for the treatment of cancer.
Choy H
Expert Rev Anticancer Ther; 2006 Jul; 6(7):973-82. PubMed ID: 16831070
[TBL] [Abstract][Full Text] [Related]
13. Free radical-induced redox chemistry of Nedaplatin and Satraplatin under physiological conditions.
Swancutt KL; Mezyk SP; Kiddle JJ
Radiat Res; 2010 Jun; 173(6):843-8. PubMed ID: 20518664
[TBL] [Abstract][Full Text] [Related]
14. The second-generation anticancer drug Nedaplatin: a theoretical investigation on the hydrolysis mechanism.
Alberto ME; Lucas MF; Pavelka M; Russo N
J Phys Chem B; 2009 Oct; 113(43):14473-9. PubMed ID: 19778071
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
16. Rapid biotransformation of satraplatin by human red blood cells in vitro.
Carr JL; Tingle MD; McKeage MJ
Cancer Chemother Pharmacol; 2002 Jul; 50(1):9-15. PubMed ID: 12111106
[TBL] [Abstract][Full Text] [Related]
17. Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
Bell DN; Liu JJ; Tingle MD; Rattel B; Meyer TU; McKeage MJ
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1440-6. PubMed ID: 18671714
[TBL] [Abstract][Full Text] [Related]
18. A Dogma in Doubt: Hydrolysis of Equatorial Ligands of Pt
Kastner A; Poetsch I; Mayr J; Burda JV; Roller A; Heffeter P; Keppler BK; Kowol CR
Angew Chem Int Ed Engl; 2019 May; 58(22):7464-7469. PubMed ID: 30870571
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
20. An experimental and theoretical investigation into the hydrolysis of dichloro(ethylenediamine)platinum(II) via electrospray mass spectrometry and density functional theory.
Yoshikawa A; Bach SB; Merrill GN
J Am Soc Mass Spectrom; 2009 Jun; 20(6):1015-29. PubMed ID: 19285881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
